COMMUNIQUÉS West-GlobeNewswire

Dova Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
02/01/2019
DURHAM, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Dr. David Zaccardelli, President and Chief Executive Officer, will present a company overview at the 37 th [...]
Radius Health to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
WALTHAM, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that President and Chief Executive Officer, Jesper Høiland, will present a corporate update at the 37 th Annual J.P. [...]
GBT to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 37 th Annual J.P. Morgan Healthcare Conference on Tuesday, [...]
Otonomy to Present at the J.P. Morgan Healthcare Conference
02/01/2019
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D [...]
Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
02/01/2019
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02/01/2019
EMERYVILLE, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
Intercept to Present at Upcoming Investor Conference
02/01/2019
NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
GAITHERSBURG, Md., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will present at the 37th Annual J.P. Morgan Healthcare Conference. Presentation details are as follows: Date and [...]
OrthoPediatrics Corp. Files Sanctions Motion Against a Former Employee and WishBone Medical, Inc.
02/01/2019
WARSAW, Indiana, Jan. 02, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today issued a statement from [...]
Orchard Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019
02/01/2019
BOSTON and LONDON, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
02/01/2019
BOSTON, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today announced that on [...]
CeGaT receives California CLIA State License and Accreditation - expanding diagnostic services in California
02/01/2019
BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- CeGaT GmbH is a CLIA certified laboratory for high complexity testing (CLIA# 99D2130225) approved by US authorities (Centers of Medicare & Medicaid Services- [...]
Amedisys to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
BATON ROUGE, La., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, today announced that Paul B. Kusserow, President and Chief Executive [...]
Creso Looks to Capitalize on Domestic & Foreign Legislation -- CFN Media
02/01/2019
SEATTLE, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Exagen enters second-year agreement with GSK to drive greater awareness about challenges facing lupus diagnosis and management
02/01/2019
Albuquerque, NM and San Diego, CA, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Exagen, a leader in rheumatology testing, today announced that it has extended its agreement with GSK, one of the world’s leading healthcare companies [...]
NICOX : Number of voting rights as of December 31.2018
02/01/2019
Nicox SA Société anonyme with a registered capital of € 29,715,320 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On January 2, 2019, MONTHLY PUBLICATION OF THE [...]
NICOX : Nombre de droits de vote au 31 décembre 2018
02/01/2019
Nicox SA Société anonyme au capital de 29 715 320 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 2 janvier 2019, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Merus annonce une collaboration stratégique avec Betta Pharmaceuticals pour développer et commercialiser le MCLA-129 en Chine
02/01/2019
Merus conserve tous les droits à l’échelle mondiale hors Chine Betta Pharmaceuticals financera les activités mondiales nécessaires à la soumission d'une IND UTRECHT (Pays-Bas), 02 janv. 2019 (GLOBE NEWSWIRE) -- Merus N. [...]
Easton Pharmaceuticals Announces Signing and Commencement of $2,600,000 Framing Contract to Construct 150 Homes
02/01/2019
TORONTO, ON, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Announces that it has closed on a Construction Agreement and has started operations on a $2,600,000 CDN framing [...]

Pages